Annie Arvidsson
- Oncology
- Pharmacology top 5%
- Pediatrics, Perinatology and Child Health top 10%
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Co-authors
- Bo AngelinGunnar AlvánMagnus BorgaAnna M. HedmanCarl Erik NordBirgitta StrandvikRune DahlqvistR. Dahlqvist
- Topics
- Antibiotics Pharmacokinetics and Efficacy (10 papers)Drug Transport and Resistance Mechanisms (8 papers)Potassium and Related Disorders (4 papers)
- Partner nations
- SwedenUnited StatesFinland
In The Last Decade
Annie Arvidsson
23 papers receiving 680 citations
Peers
Comparison fields: 5 of 95
- Oncology 218
- Pharmacology 180
- Pediatrics, Perinatology and Child Health 175
- Pulmonary and Respiratory Medicine 155
- Molecular Biology 113
Countries citing papers authored by Annie Arvidsson
This map shows the geographic impact of Annie Arvidsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Arvidsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Arvidsson more than expected).
Fields of papers citing papers by Annie Arvidsson
This network shows the impact of papers produced by Annie Arvidsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Arvidsson. The network helps show where Annie Arvidsson may publish in the future.
Co-authorship network of co-authors of Annie Arvidsson
This figure shows the co-authorship network connecting the top 25 collaborators of Annie Arvidsson. A scholar is included among the top collaborators of Annie Arvidsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Arvidsson. Annie Arvidsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 57 | |
| 2 | 65 | |
| 3 | 3 | |
| 4 | 22 | |
| 5 | 51 | |
| 6 | 7 | |
| 7 | 24 | |
| 8 | 20 | |
| 9 | 56 | |
| 10 | 56 | |
| 11 | 22 | |
| 12 | 26 | |
| 13 | 31 | |
| 14 | 49 | |
| 15 | 23 | |
| 16 | 1 | |
| 17 | 32 | |
| 18 | 11 | |
| 19 | 23 | |
| 20 | 16 |
About Annie Arvidsson
Annie Arvidsson is a scholar working on Applied Microbiology and Biotechnology, Pharmacology and Nephrology, having authored 23 papers that have together received 722 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Drug Transport and Resistance Mechanisms (8 papers) and Potassium and Related Disorders (4 papers). The work is most often cited by research in Molecular Medicine (77 citations), Developmental Neuroscience (44 citations) and Pharmacology (180 citations). Annie Arvidsson has collaborated with scholars based in Sweden, United States and Finland. Frequent co-authors include Bo Angelin, Gunnar Alván, Magnus Borga, Anna M. Hedman, Carl Erik Nord, Birgitta Strandvik, Rune Dahlqvist, R. Dahlqvist, Karin Schenck‐Gustafsson and Matti S. Airaksinen. Their work appears in journals such as Journal of Applied Physiology, Neuroscience and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.